Bioxytran Inc (BIXT)
0.0978
+0.01
(+7.48%)
USD |
OTCM |
Nov 05, 15:47
Bioxytran Market Cap: 8.385M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 7.802M |
| November 01, 2024 | 7.978M |
| October 31, 2024 | 7.720M |
| October 30, 2024 | 7.806M |
| October 29, 2024 | 8.492M |
| October 28, 2024 | 8.149M |
| October 25, 2024 | 7.548M |
| October 24, 2024 | 6.998M |
| October 23, 2024 | 9.413M |
| October 22, 2024 | 9.413M |
| October 21, 2024 | 8.846M |
| October 18, 2024 | 9.004M |
| October 17, 2024 | 9.004M |
| October 16, 2024 | 8.808M |
| October 15, 2024 | 8.021M |
| October 14, 2024 | 8.594M |
| October 11, 2024 | 9.004M |
| October 10, 2024 | 9.004M |
| October 09, 2024 | 8.742M |
| October 08, 2024 | 8.185M |
| October 07, 2024 | 8.003M |
| October 04, 2024 | 9.167M |
| October 03, 2024 | 9.245M |
| October 02, 2024 | 8.926M |
| October 01, 2024 | 8.907M |
| Date | Value |
|---|---|
| September 30, 2024 | 9.004M |
| September 27, 2024 | 9.190M |
| September 26, 2024 | 9.310M |
| September 25, 2024 | 8.660M |
| September 24, 2024 | 8.578M |
| September 23, 2024 | 7.727M |
| September 20, 2024 | 7.129M |
| September 19, 2024 | 8.157M |
| September 18, 2024 | 6.376M |
| September 17, 2024 | 6.548M |
| September 16, 2024 | 6.704M |
| September 13, 2024 | 7.088M |
| September 12, 2024 | 6.712M |
| September 11, 2024 | 7.080M |
| September 10, 2024 | 6.560M |
| September 09, 2024 | 7.088M |
| September 06, 2024 | 6.683M |
| September 05, 2024 | 6.706M |
| September 04, 2024 | 7.350M |
| September 03, 2024 | 7.328M |
| August 30, 2024 | 6.998M |
| August 29, 2024 | 7.326M |
| August 28, 2024 | 6.875M |
| August 27, 2024 | 7.366M |
| August 26, 2024 | 8.267M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.0202M
Minimum
Jun 09 2021
139.37M
Maximum
Sep 06 2022
26.12M
Average
20.25M
Median
Nov 20 2023
Market Cap Benchmarks
| Gossamer Bio Inc | 198.92M |
| NovaBay Pharmaceuticals Inc | 3.762M |
| Palatin Technologies Inc | 22.87M |
| iBio Inc | 23.24M |
| Theriva Biologics Inc | 1.970M |
Market Cap Related Metrics
| PS Ratio | 69.16 |
| Price | 0.0978 |
| Earnings Yield | -12.04% |